M&T Bank’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-4,120
| Closed | -$415K | – | 1559 |
|
|
2021
Q3 | $415K | Sell |
4,120
-43
| -1% | -$4.33K | ﹤0.01% | 1090 |
|
|
2021
Q2 | $589K | Sell |
4,163
-424
| -9% | -$60K | ﹤0.01% | 956 |
|
|
2021
Q1 | $457K | Sell |
4,587
-1,247
| -21% | -$124K | ﹤0.01% | 1041 |
|
|
2020
Q4 | $721K | Buy |
5,834
+57
| +1% | +$7.04K | ﹤0.01% | 896 |
|
|
2020
Q3 | $562K | Sell |
5,777
-375
| -6% | -$36.5K | ﹤0.01% | 924 |
|
|
2020
Q2 | $960K | Buy |
6,152
+2,902
| +89% | +$453K | 0.01% | 695 |
|
|
2020
Q1 | $469K | Sell |
3,250
-250
| -7% | -$36.1K | ﹤0.01% | 933 |
|
|
2019
Q4 | $716K | Hold |
3,500
| – | – | ﹤0.01% | 728 |
|
|
2019
Q3 | $281K | Sell |
3,500
-9
| -0.3% | -$723 | ﹤0.01% | 1242 |
|
|
2019
Q2 | $331K | Buy |
3,509
+250
| +8% | +$23.6K | ﹤0.01% | 1175 |
|
|
2019
Q1 | $279K | Buy |
+3,259
| New | +$279K | ﹤0.01% | 1244 |
|
|
2018
Q4 | – | Sell |
-2,500
| Closed | -$204K | – | 1524 |
|
|
2018
Q3 | $204K | Buy |
+2,500
| New | +$204K | ﹤0.01% | 1427 |
|